140410.KQ Mezzion Pharma Co.,Ltd.
KOEHealthcareAs of 2026-08-09 03:24
Why 140410.KQ matters now
Mezzion Pharma Co.,Ltd. (140410.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩54,500.00 with -1.80% on the session and ₩1.67T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -44.69, gross margin 5.8%, and operating margin -161.8%.
Valuation
P/E (TTM)
-44.69
PEG
—
P/B
106.77
P/S
207.78
EV/EBITDA
-128.65
DCF Value
—
FCF Yield
-1.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
5.8%
Operating Margin
-161.8%
Net Margin
-463.2%
ROE
-132.8%
ROA
-37.3%
ROIC
-41.6%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
KR
Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.